Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M125Revenue $M49.1Net Margin (%)-74.5Altman Z-Score-1.1
Enterprise Value $M85.1EPS $-0.5Operating Margin %-76.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score9.7Pre-tax Margin (%)-74.5Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %-6.8Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %4.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-50.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.3ROIC % (ttm)-229.6Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRXGeorge Soros 2014-06-30 Sold Out -0.01%$7.37 - $12.52
($9.68)
$ 1.71-82%Sold Out0
BCRXGeorge Soros 2014-03-31 Buy 0.01%$7.6 - $12.83
($10.56)
$ 1.71-84%New holding59,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAKER BROS. ADVISORS LP10% Owner 2016-02-05Buy45,000$6.33-72.99view
BAKER BROS. ADVISORS LP10% Owner 2016-02-04Buy207,715$6.43-73.41view
BAKER BROS. ADVISORS LP10% Owner 2016-01-28Buy88,345$6.95-75.4view
BAKER BROS. ADVISORS LP10% Owner 2016-01-22Buy106,800$7.28-76.51view
BAKER BROS. ADVISORS LP10% Owner 2016-01-20Buy344,895$7.28-76.51view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-21Sell3,052$10.86-84.25view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-17Sell3,000$10.49-83.7view
STAAB THOMAS R IISenior Vice President and CFO 2015-07-20Sell3,500$16.5-89.64view
STAAB THOMAS R IISenior Vice President and CFO 2015-06-22Sell3,750$16-89.31view
Barnes Alane PVP, General Counsel & Corp Sec 2015-06-19Sell3,000$15-88.6view

Quarterly/Annual Reports about BCRX:

    News about BCRX:

    Articles On GuruFocus.com
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 2,500 Shares Aug 06 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares Jun 04 2010 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares May 05 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 38,553 Shares Apr 30 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,249 Shares Apr 06 2010 

    More From Other Websites
    The Zacks Analyst Blog Highlights: Regeneron, Alexion, CTI BioPharma, BioCryst and Sarepta Feb 11 2016
    Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma Feb 10 2016
    BioCryst Pharmaceuticals (BCRX) in Focus: Stock Jumps 6.2% Feb 10 2016
    The fate of Heat Biologics, BioCryst could lie in the coming weeks Feb 09 2016
    BioCryst (BCRX) Stock Downgraded at Jefferies Feb 09 2016
    Company News for February 09, 2016 Feb 09 2016
    BioCryst Downgraded By JPMorgan, Analysts Await 'More Data' Feb 09 2016
    BioCryst Pharma downgraded by JP Morgan, Jefferies and Needham Feb 09 2016
    BioCryst (BCRX) Stock Plummets on Disappointing Trial Results Feb 08 2016
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of... Feb 08 2016
    Is BioCryst Reaching Crush Depth? Feb 08 2016
    BioCryst stock nose dives 60-plus percent after trial results Feb 08 2016
    BioCryst Pharmaceuticals Is Plummeting 65% Feb 08 2016
    [$$] BioCryst Angioedema Drug Fails in Midstage Study Feb 08 2016
    BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 08 2016
    BioCryst Announces Results From OPuS-2 Feb 08 2016
    WHO Declares Zika A Health Emergency of International Concern: 5 Companies Developing Technologies... Feb 03 2016
    Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves Jan 28 2016
    5 Stocks Insiders Love Right Now Jan 27 2016
    Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End... Jan 23 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK